PAINCEPTOR Logo (USPTO, 12.10.2005)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke PAINCEPTOR wurde als Wort-Bildmarke am 12.10.2005 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE".
Markeninhaber
7150, Albert-Einstein
H4S 2C1 St-Laurent , Quebec
CA
H4S 2C1 St-Laurent , Quebec
CA
Markenvertreter
Waren und Dienstleistungen
5
Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Schizophrenia, learning disorders, Bipolar Disorder, Depression, Alzheimer's Disease, Epilepsy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Stroke, Addiction, Cerebral Ischemia, Neuropathy, Retinal Pigment Degeneneration, Glaucoma, Cardiac Arrhythmia, Shingles, Huntington's Chorea, Parkinson's Disease and anxiety disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases of the musculoskeletal and connective tissue system, Respiratory system, Circulatory system, Gastrointestinal system, Genitourinary system and Nervous system; Pharmaceutical preparations for the treatment of diseases and disorders of the musculoskeletal and connective tissue system, namely, Arthritis, Psoriasis, Myocitis, Dermatitis, bone cancer and eczema; Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system, namely, Asthma, Bronchitis, Sinusitis, Pharyngitis, Laryngitis, Tracheitis, rhinitis, Cystic fibrosis, Respiratory Infection, Acute respiratory Distress syndrome and emphysema; Pharmaceutical preparations for the treatment of diseases and disorders of the circulatory system, namely, Vasculitis, Haematuria syndrome, Artherosclerosis, Arteritis, Phlebitis, Carditis, Coronary Heart Disease, Ischemic Heart Disease, Angina and Acute Myocardial Infarction; Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, namely, Irritable Bowel Syndrome, Ulcerative colitis, Crohn's Disease, Diverticulitis, Viral and Bacterial Infection, Peptic ulcer, Chronic hepatitis, Gingivitis, Periodentitis, Stomatitis, Gastritis, Gastrointestinal reflux disease and GI cancers; Pharmaceutical preparations for the treatment of the genitourinary diseases and disorders, namely, Cystitis, Polycystic kidney disease, Nephritic syndrome, Urinary Tract infection, Kidney Stones, Cystinosis, Prostatitis, Salpingitis, Endometriosis and GU cancers; Pharmaceutical preparations for the treatment of diseases and disorders of the nervous system, namely, Neuralgia, Neuropathy, Chronic cephalic pain, headache, migraine, psychogenic pain and spinal cord injury
42
Pharmaceutical research and development, product evaluation and drug development
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378731402